Surgical Pathologist
NeoGenomics Laboratories
Summary
This is a staff-level position within the NeoGenomics Medical team that will work supporting hospital-based clients. The role will provide expert diagnostic information focused on complex oncologic pathology and will analyze clinical laboratory data to provide professional pathological opinions on Surgical Pathology cases. The ideal candidate will be an experienced well-rounded Surgical Pathologist with complex oncologic pathology expertise and an interest in breast pathology.
Job description
Position Summary
This is a staff-level position within the NeoGenomics Medical team that will work supporting hospital-based clients. The role will provide expert diagnostic information focused on complex oncologic pathology and will analyze clinical laboratory data to provide professional pathological opinions on Surgical Pathology cases. The ideal candidate will be an experienced well-rounded Surgical Pathologist with complex oncologic pathology expertise and an interest in breast pathology.
Responsibilities
- Focus on diagnostic Surgical Oncologic case sign out and service
- Perform frozen section evaluations, as needed
- Render expert gross and/or microscopic diagnoses, incorporating advanced molecular or genetic information when appropriate
- Perform delegated medical director duties with regards to both anatomic and clinical laboratories
- Share equally in hospital pathology on-call schedules and tumor board responsibilities
- Read and interpret clinical laboratory data and provide professional consultation on clinical pathology inquiries
- Perform quality control and quality assurance procedures and participate in departmental professional quality control and quality assurance activities
- Assist the laboratory administrative director and Pathology Chair in delegated supervision of technical and support staff
- Work closely with clinical and administrative staff at the NeoGenomics Hospital Client as well as NeoGenomics leadership to ensure the highest standards of turnaround time, quality, and customer service are maintained
- Provide expertise and assistance to technologists and technicians to resolve case issues
Experience, Education and Qualifications
- M.D. or D.O degree and board certification in Anatomic and Clinical Pathology required
- Three years of post-residency experience preferred
- Breast pathology fellowship strongly preferred but not required
- Must hold valid unrestricted license to practice medicine in FL or be eligible to obtain licensure
- Strong customer focus and understanding of hospital/laboratory operations
- Ability to fulfill CLIA '88 if required
Requirements
- M.D. or D.O. degree
- Board certification in Anatomic and Clinical Pathology
- Three years of post-residency experience preferred
- Breast pathology fellowship strongly preferred
- Valid unrestricted license to practice medicine in FL or eligible to obtain licensure
- Strong customer focus and understanding of hospital/laboratory operations
- Ability to fulfill CLIA '88 if required
Benefits
- Sign-on Bonus
- Equity Participation
- Annual Bonus
- Paid Time Off
- CME Leave
- Education Stipend
- Licensing Fee Coverage
- Relocation Assistance
Company overview
NeoGenomics Laboratories, Inc. is a premier cancer diagnostics company specializing in comprehensive cancer genetics testing and oncology data solutions. Founded in 2002 and headquartered in Fort Myers, Florida, the company operates as a publicly traded entity on Nasdaq under the ticker NEO. NeoGenomics provides one of the most extensive oncology-focused testing menus worldwide, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with innovative diagnostic and predictive testing services. The company's testing portfolio includes cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics, with a particular emphasis on next-generation sequencing (NGS) technologies. With approximately 2,200 employees across 13 locations in the United States and Europe, NeoGenomics processes over 1.7 million cancer-related tests annually, including more than 100,000 NGS tests, serving about 4,400 medical sites and providing answers to more than 500,000 patients each year. The company maintains CAP-accredited and CLIA-certified laboratories throughout its network and has established a significant presence in cancer research through its Pharma Services Division, which supports pharmaceutical clients in clinical trials and drug development.